BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19799091)

  • 1. [Clinical analysis of 215 elderly patients with cervical cancer].
    Cheng M; Wu LY; Zhang WH; Huang MN; Zhang R
    Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):388-91. PubMed ID: 19799091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Postoperative simultaneous radiochemotherapy improves survival in patients with cervical carcinoma].
    Dunst J
    Strahlenther Onkol; 2000 Oct; 176(10):486-7. PubMed ID: 11068599
    [No Abstract]   [Full Text] [Related]  

  • 3. Stage-adjusted chemoradiation in cervical cancer after transperitoneal laparoscopic staging.
    Marnitz S; Köhler C; Roth C; Füller J; Bischoff A; Wendt T; Schneider A; Budach V
    Strahlenther Onkol; 2007 Sep; 183(9):473-8. PubMed ID: 17762920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment patterns and outcomes in bulky stage IB2 cervical cancer patients: a single institution's experience over 14 years.
    Kim WY; Chang SJ; Chang KH; Yoo SC; Chun M; Ryu HS
    Gynecol Obstet Invest; 2011; 71(1):19-23. PubMed ID: 21160190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Operative treatment of advanced cervical cancer after full pelvic irradiation.
    Leino R; Grénman S; Rantanen V; Kiilholma P; Salmi T
    Ann Chir Gynaecol Suppl; 1994; 208():50-3. PubMed ID: 8092773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes.
    Kim YS; Kim JH; Ahn SD; Lee SW; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1522-8. PubMed ID: 19231106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is adjuvant chemoradiotherapy overtreatment in cervical cancer patients with intermediate risk factors?
    Ryu SY; Park SI; Nam BH; Cho CK; Kim K; Kim BJ; Kim MH; Choi SC; Lee ED; Lee KH
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):794-9. PubMed ID: 20421158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
    Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution.
    Parker K; Gallop-Evans E; Hanna L; Adams M
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):140-6. PubMed ID: 18922646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glassy cell carcinoma of the cervix].
    Dieterle S; Mesrogli M; Günter HH; Kühnle H
    Geburtshilfe Frauenheilkd; 1991 Jun; 51(6):484-5. PubMed ID: 1909675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification for failure in patients with advanced cervical cancer after concurrent chemoradiotherapy: another way to optimise treatment results.
    Liang JA; Chen SW; Chang WC; Hung YC; Yeh LS; Yang SN; Lin FJ
    Clin Oncol (R Coll Radiol); 2008 Nov; 20(9):683-90. PubMed ID: 18676129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preoperative concurrent chemotherapy and radiation therapy in cervix cancer: preliminary results].
    Kochbati L; Ben Ammar CN; Benna F; Hechiche M; Boussen H; Besbes M; Ben Abdallah M; Rahal K; Ben Ayed F; Ben Romdhane K; Maalej M
    Tunis Med; 2005 Mar; 83(3):146-9. PubMed ID: 15929442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma].
    Zeng SY; Li LY; Shu KY; Pan M; Li HP; Luo B
    Ai Zheng; 2008 Sep; 27(9):942-6. PubMed ID: 18799032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in patients with with locally advanced cervical cancer treated with radical hysterectomy and adjuvant radiotherapy.
    Frigerio L; Mariani A; Gandini L; Origoni M; Galli L; Rabaiotti E; Aletti G; Ferrari A
    Int Surg; 1998; 83(3):265-70. PubMed ID: 9870789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Para-aortic involvement and interest of para-aortic lymphadenectomy after chemoradiation therapy in patients with stage IB2 and II cervical carcinoma radiologically confined to the pelvic cavity.
    Delpech Y; Haie-Meder C; Rey A; Zafrani Y; Uzan C; Gouy S; Pautier P; Lhommé C; Duvillard P; Castaigne D; Morice P
    Ann Surg Oncol; 2007 Nov; 14(11):3223-31. PubMed ID: 17713822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preoperative chemoradiation in esophageal cancer: experience of a single center in 102 patients].
    Imdahl A; Schöffel U; Ruf G; Hopf UT
    Zentralbl Chir; 2004 Oct; 129(5):350-5. PubMed ID: 15486784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surgical intervention for the central recurrence or persistent local lesion of uterine cervical carcinoma following full-dose radiotherapy].
    Bai P; Ma Y; Li W; Zhang R
    Zhonghua Zhong Liu Za Zhi; 2010 Jan; 32(1):52-5. PubMed ID: 20211069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up results of irradiation alone or combined with surgery in stage I-IV carcinoma of the uterine cervix.
    Reinartz G; Bartsch S; Willich N
    Zentralbl Gynakol; 2000; 122(6):318-23. PubMed ID: 10904995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
    Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG
    J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.